FIELD: medicine.
SUBSTANCE: invention refers to diagnostics, namely to a method for diagnosing preeclampsia by amino acid profile of blood plasma. A method for diagnosing preeclampsia by blood plasma amino acid profile involves quantitatively determining concentration of 3 amino acids – carnosine, arginine and ethanolamine – in blood plasma by chromatography-mass spectrometry; calculating the value of the estimated parameter (Y) by an empirical formula, and the Y≥-0.59 value making shows the development of preeclampsia, while Y<-0.59 concludes that the pregnancy takes place within the individual physiological norm.
EFFECT: method described above enables high-accuracy identification of possible marker molecules and diagnosing preeclampsia.
1 cl, 5 dwg, 3 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE RISK OF PREECLAMPSIA IN PREGNANT WOMEN WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS | 2020 |
|
RU2751139C1 |
| METHOD OF PREDICTING THE DEVELOPMENT OF HYPERTENSIVE DISORDERS DURING PREGNANCY IN THE MIDDLE RISK GROUP AMONG THE WOMEN WHO UNDERWENT COMBINED SCREENING OF THE 1ST TRIMESTER | 2023 |
|
RU2803010C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PREECLAMPSIA | 2023 |
|
RU2817206C1 |
| METHOD OF PREDICTING THE RECURRENCE OF EARLY SEVERE PREECLAMPSIA BASED ON THE RESULTS OF A STUDY OF THE LEVEL OF PLACENTAL MICROVESICLES IN BLOOD PLASMA IN PATIENTS WITH SEVERE PREECLAMPSIA IN A PERSONAL HISTORY | 2022 |
|
RU2798715C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING PREECLAMPSIA IN PREGNANT WOMEN WITH VARIOUS TYPES OF DIABETES MELLITUS | 2021 |
|
RU2767912C1 |
| PREDICTION OF PREECLAMPSIA BASED ON DETERMINING EXTRACELLULAR FETAL DNA IN MATERNAL BLOOD WHEN SCREENING THE FIRST TRIMESTER OF PREGNANCY | 2019 |
|
RU2697845C1 |
| METHOD OF PREDICTING THE RISK OF PRE-ECLAMPSIA IN PREGNANT WOMEN WITH TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2800716C1 |
| METHOD FOR FORECASTING SEVERITY OF EARLY PREECLAMPSY | 2021 |
|
RU2753463C1 |
| METHOD FOR PREDICTION OF RISK OF PREECLAMPSIA | 2014 |
|
RU2578425C2 |
| METHOD FOR PREECLAMPSIA SEVERITY DIAGNOSTICS BASED ON EVALUATION OF DNA-RECOGNIZING DAI-1 RECEPTORS EXPRESSION IN PLACENTAL TISSUE | 2017 |
|
RU2641029C1 |
